Lista de obras - Laurent Peyrin-Biroulet - Dominio Público Uruguay

"Comment on a retraction": author response.

artículo científico publicado en 2009

25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients

artículo científico publicado en 2016

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management

artículo científico publicado en 2016

5-Aminosalicylates and renal function monitoring in inflammatory bowel disease: a nationwide survey

artículo científico publicado en 2012

5-Aminosalicylic acid and chemoprevention: does it work?

artículo científico publicado en 2013

A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.

artículo científico publicado en 2008

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool

artículo científico publicado en 2020

A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials

artículo científico publicado en 2019

A Systematic Review for the Development of a Core Outcome Set for Ulcerative Colitis Clinical Trials

artículo científico publicado en 2017

A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases

artículo científico publicado en 2015

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review ⬇️

artículo científico publicado en 2019

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

scientific article published on 22 December 2019

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization

artículo científico publicado en 2010

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

artículo científico publicado en 2019

A practical guide for faecal calprotectin measurement: myths and realities

artículo científico publicado en 2020

A practical guide to assess the Nancy histological index for UC.

artículo científico publicado en 2016

A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease

artículo científico publicado en 2016

A snapshot of the ongoing clinical research on COVID-19

artículo científico publicado en 2020

Accuracy of Diffusion-weighted Magnetic Resonance Colonography in Assessing Mucosal Healing and the Treatment Response in Patients with Ulcerative Colitis

artículo científico publicado en 2017

Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease

scientific article published on 01 November 2018

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study.

artículo científico publicado en 2018

Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer

artículo científico publicado en 2019

Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.

artículo científico publicado en 2013

Acute hepatic cytolysis following H1N1 vaccination in a patient with Crohn's disease on infliximab

scientific article published on 01 February 2011

Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study

scientific article published on 01 January 2019

Adalimumab in ulcerative colitis: hypes and hopes

artículo científico publicado en 2011

Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study

artículo científico publicado en 2007

Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials

artículo científico publicado en 2020

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

scientific article published on 24 January 2020

Addressing current treatment challenges in Crohn's disease in real life: a physician's survey

artículo científico publicado en 2014

Adherence to adalimumab therapy in Crohn's disease: a French multicenter experience.

artículo científico publicado en 2011

Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review

artículo científico

Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting

artículo científico publicado en 2017

Advances in the treatment of ulcerative colitis

artículo científico publicado en 2013

An Anti-Migration Self-Expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From the Getaid and the Sfed

artículo científico publicado en 2020

An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis

artículo científico publicado en 2014

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials

artículo científico publicado en 2021

Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience

artículo científico publicado en 2016

Anti-TNF Therapy in Inflammatory Bowel Diseases

Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach

scientific article published on 26 July 2019

Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

scientific article published on 07 September 2018

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?

scientific article published on 01 January 2019

Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?

scientific article published on 01 January 2019

Anti-tumor necrosis factor-α monotherapy versus combination therapy with an immunomodulator in IBD.

artículo científico publicado en 2014

Antimycobacterial therapy in Crohn's disease: game over?

artículo científico publicado en 2007

Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?

scientific article published on 19 November 2020

Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases

scientific article published on 19 June 2019

Are we improving disease outcomes in IBD? A view from the epidemiology side

artículo científico publicado en 2013

Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials

artículo científico publicado en 2020

Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis

artículo científico publicado en 2014

Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.

artículo científico publicado en 2013

Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn's disease

artículo científico publicado en 2007

Author Correction: Crohn's disease

scientific article published on 20 May 2020

Author Correction: Crohn's disease

scientific article published on 19 June 2020

Author Correction: Head-to-head trials in inflammatory bowel disease: past, present and future

scientific article published on 05 January 2021

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis

artículo científico publicado en 2009

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.

artículo científico publicado en 2017

Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study

artículo científico publicado en 2016

Azathioprine in Early Crohn’s Disease: Time to Revisit Patient Selection and End Points for Clinical Trials and/or Azathioprine Efficacy?

Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response

artículo científico publicado en 2012

Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic

scientific article published on 15 May 2020

Beclomethasone dipropionate: a second chance for topical steroids as maintenance therapy in ileal Crohn's disease

artículo científico publicado en 2011

Beliefs and behaviour about smoking among inflammatory bowel disease patients

artículo científico publicado en 2015

Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?

artículo científico publicado en 2015

Big data in IBD: a look into the future

artículo científico publicado en 2019

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.

artículo científico publicado en 2016

Biologic agents for IBD: practical insights

artículo científico

Biologic therapies in ulcerative colitis: primi inter pares?

artículo científico publicado en 2016

Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis

artículo científico publicado en 2014

Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13.

artículo científico

Biosimilar switching in inflammatory bowel disease: from evidence to clinical practice

scientific article published on 21 September 2020

Biosimilars for the management of inflammatory bowel diseases: economic considerations

artículo científico publicado en 2017

Biosimilars in IBD: from theory to practice

artículo científico publicado en 2016

Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

artículo científico publicado en 2019

Biosimilars of adalimumab: the upcoming challenge in IBD

artículo científico publicado en 2019

Bowel Damage Assessment in Crohn’s Disease by Magnetic Resonance Imaging ⬇️

artículo científico publicado el 1 de septiembre de 2012

Bowel Damage as Assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn’s Disease

artículo científico publicado en 2015

Bowel Damage at Diagnosis Using the Lémann Index Score in Saudi Arabian Patients With Crohn's Disease

artículo científico publicado en 2020

Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile

artículo científico publicado en 2017

Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study

artículo científico publicado en 2016

CARD8 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease

artículo científico publicado en 2015

Can elderly people be treated safely with anti-TNF agents?

artículo científico publicado en 2011

Cancer and inflammatory bowel disease in the elderly

artículo científico publicado en 2016

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study

artículo científico publicado en 2016

Capsule endoscopy in Crohn's disease

artículo científico publicado en 2012

Challenges and opportunities for IBD drug development: from early stage to regulatory approval

artículo científico publicado en 2020

Challenges in the Pathophysiology, Diagnosis and Management of Intestinal Fibrosis in Inflammatory Bowel Disease

artículo científico publicado en 2019

Changes in inflammatory bowel disease patients' perspectives on biosimilars: A follow-up survey

artículo científico publicado en 2019

Characteristics Of Lymphoma In Patients With Inflammatory Bowel Disease: A Systematic Review

scientific article published on 19 September 2020

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

artículo científico publicado en 2015

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease

artículo científico publicado en 2020

Clinical Research and Trials-A "Nonessential" Victim of the COVID-19 Pandemic?

artículo científico publicado en 2020

Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic

artículo científico publicado en 2020

Clinical development of biologicals and biosimilars - safety concerns

scientific article published on 05 May 2017

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

artículo científico publicado en 2013

Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis

scientific article published on 22 June 2018

Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus

artículo científico publicado en 2020

Clinical implications of mucosal healing for the management of IBD.

artículo científico publicado en 2009

Clinical pharmacists and patients with inflammatory bowel diseases: are we ready for the multidisciplinary approach?

artículo científico publicado en 2021

Clinical remission as defined by the Mayo Score: do we deceive ourselves?

artículo científico publicado en 2015

Clinical risk factors for complicated disease: how reliable are they?

artículo científico

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

artículo científico publicado en 2020

Clinical trials in luminal Crohn's disease: a historical perspective

artículo científico

Clinical trials in ulcerative colitis: a historical perspective

artículo científico

Clinical, endoscopic and histological outcomes in induction of moderate-to-severe ulcerative colitis: a systematic review with meta-analysis

artículo científico publicado en 2020

Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial

artículo científico publicado en 2020

Coffee and diabetes: is homocysteine the missing link?

artículo científico publicado en 2007

Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis

scientific article published on 01 November 2006

Colonoscopic perforations in inflammatory bowel disease: a retrospective study in a French referral centre

artículo científico publicado en 2013

Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).

artículo científico publicado en 2012

Colorectal cancer prevention in patients with ulcerative colitis

artículo científico publicado en 2018

Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab

artículo científico publicado en 2020

Combination of C-reactive protein, infliximab trough levels, and stable but not transient antibodies to infliximab are associated with loss of response to infliximab in inflammatory bowel disease

artículo científico publicado en 2015

Combination therapy with methotrexate in inflammatory bowel disease: time to COMMIT?

scientific article published on 24 January 2014

Comorbidities in inflammatory bowel disease: a call for action

artículo científico publicado en 2019

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

artículo científico publicado en 2017

Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn’s Disease and Guiding Clinical Decision-making

artículo científico publicado en 2018

Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease

scientific article published on 22 April 2020

Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis

artículo científico publicado en 2019

Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis.

artículo científico publicado en 2017

Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study

scientific article published on 22 March 2020

Comparing histological activity indexes in UC.

artículo científico publicado en 2014

Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease

artículo científico publicado en 2013

Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development

scientific article published on 26 October 2018

Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn's Disease

scientific article published on 16 November 2019

Compliance with the faecal calprotectin test in patients with inflammatory bowel disease

artículo científico

Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion

artículo científico publicado en 2013

Conditions of prescription of anti-TNF agents in newly treated patients with inflammatory bowel disease in France (2011-2013).

artículo científico publicado en 2016

Confounding and bias in observational studies in inflammatory bowel disease: a meta-epidemiological study

scientific article published on 09 December 2020

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

scientific article published on 01 April 2019

Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease

artículo científico publicado en 2016

Correction to: Crohn's Disease Only Visible on Small Bowel Capsule Endoscopy: A New Entity

scientific article published on 25 September 2020

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 02 June 2020

Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab

artículo científico publicado en 2015

Cost savings using a test-based de-escalation strategy for patients with Crohn's disease in remission on optimized infliximab: A discrete event model study

scientific article published on 05 September 2018

Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe

artículo científico publicado en 2017

Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review

artículo científico publicado en 2016

Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience

artículo científico publicado en 2019

Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe

artículo científico publicado en 2017

Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab

artículo científico publicado en 2016

Crohn's disease

artículo científico publicado en 2016

Crohn's disease: beyond antagonists of tumour necrosis factor

artículo científico publicado en 2008

Crohn's disease: the hot hypothesis

artículo científico publicado en 2009

Crohn’s disease

artículo científico publicado en 2020

Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn's Disease

artículo científico publicado en 2016

Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience

artículo científico publicado en 2015

Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease

artículo científico publicado en 2016

Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases

artículo científico publicado en 2015

Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis

artículo científico publicado en 2011

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

artículo científico publicado en 2020

Deep Remission in Crohn's Disease: Is It the End of the Placebo Effect? ⬇️

artículo científico publicado el 4 de agosto de 2013

Deep remission in inflammatory bowel disease: looking beyond symptoms

artículo científico

Deep remission: a new concept?

artículo científico

Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

artículo científico publicado en 2016

Defining Severity in Inflammatory Bowel Disease

artículo científico publicado en 2015

Detection and management of early stage inflammatory bowel disease: an update for clinicians

artículo científico publicado en 2019

Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures

artículo científico publicado en 2015

Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.

artículo científico publicado en 2017

Development and validation of a patient‐reported disability measurement tool for patients with inflammatory bowel disease ⬇️

artículo científico publicado el 22 de diciembre de 2012

Development and validation of the Nancy histological index for UC.

artículo científico publicado en 2015

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative

artículo científico

Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseases.

artículo científico publicado en 2014

Development of an index to define overall disease severity in IBD.

artículo científico publicado en 2016

Development of the Crohn's disease digestive damage score, the Lémann score

artículo científico publicado en 2010

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases

scientific article published on 31 January 2017

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process

artículo científico

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health ⬇️

artículo científico publicado el 5 de junio de 2011

Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence

artículo científico

Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn's Disease Patients

artículo científico publicado en 2016

Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate

artículo científico publicado en 2013

Diagnostic delay in a French cohort of Crohn's disease patients

artículo científico publicado en 2014

Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management

scientific article published on 08 April 2020

Dietary beliefs and behavior among inflammatory bowel disease patients

artículo científico publicado en 2013

Diffusion-weighted MRI in inflammatory bowel disease

artículo científico publicado en 2018

Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease

artículo científico publicado en 2010

Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health

artículo científico publicado en 2010

Disease-Modifying Anti-Inflammatory Bowel Disease Drugs (DMAIDs): The Missing Term in the Literature ⬇️

artículo científico publicado el 1 de mayo de 2013

Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study

artículo científico publicado en 2017

Does anti-TNF therapy cost so many COINs?

artículo científico publicado en 2013

Does anti-TNF therapy reduce the requirement for surgery in ulcerative colitis? A systematic review

scientific article published on September 2011

Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study

scientific article published on 08 November 2018

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

artículo científico

E-health in inflammatory bowel diseases: More challenges than opportunities?

artículo científico publicado en 2017

ECCO Position Paper: Harmonisation of the approach to Ulcerative Colitis Histopathology

artículo científico publicado en 2020

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

artículo científico publicado en 2016

Early Combined Immunosuppression in Crohn's Disease: Acting Rather Than REACTing

artículo científico publicado en 2016

Early Crohn disease: a proposed definition for use in disease-modification trials

scientific article published on 01 February 2010

Early Intervention With Vedolizumab on Longer Term Surgery Rates in Crohn's Disease: Post Hoc Analysis of the GEMINI Phase 3 and Long-term Safety Programs

artículo científico publicado en 2020

Early Intervention in Ulcerative Colitis: Ready for Prime Time?

artículo científico publicado en 2020

Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation

artículo científico publicado en 2018

Early combined immunosuppression in Crohn's disease

artículo científico publicado en 2008

Early intervention in Crohn's disease: towards disease modification trials

artículo científico publicado en 2017

Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study.

artículo científico publicado en 2018

Editorial. Imaging inflammatory bowel disease: looking beyond the mucosa

artículo científico publicado en 2012

Editorial. Medical challanges in inflammatory bowel disease: quo vadis in disease complexity?

artículo científico publicado en 2014

Editorial: Personalized Medicine in Inflammatory Bowel Diseases: Myth or Reality?

artículo científico publicado en 2018

Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars

scientific article published on 01 September 2018

Editorial: diagnostic precision of iron deficiency in inflammatory bowel disease. Authors' reply

artículo científico publicado en 2020

Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply.

artículo científico publicado en 2018

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA.

artículo científico publicado en 2017

Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter Study

artículo científico publicado en 2020

Effectiveness Research in Inflammatory Bowel Disease: A Necessity and a Methodological Challenge

artículo científico publicado en 2016

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

artículo científico publicado en 2016

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study

artículo científico publicado en 2018

Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series

artículo científico publicado en 2018

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

scientific article published on 14 April 2020

Effectiveness of Infliximab Biosimilar in Crohn's Disease: A Dime, A Dozen

artículo científico publicado en 2019

Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting

artículo científico publicado en 2017

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study

artículo científico publicado en 2016

Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence

artículo científico publicado en 2018

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials

artículo científico

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy

artículo científico publicado en 2016

Effects of enteral polymeric diet on gut microbiota in children with Crohn's disease

article by Chloé Guinet-Charpentier et al published 27 January 2016 in Gut

Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study*

artículo científico publicado en 2011

Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease

artículo científico publicado en 2009

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis

scientific article published on 09 November 2019

Efficacy and Safety of Extended Induction with Tofacitinib for the Treatment of Ulcerative Colitis

artículo científico publicado en 2020

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis

scientific article published on 10 September 2018

Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis

artículo científico

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease

artículo científico publicado en 2020

Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.

artículo científico publicado en 2015

Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease

scientific article published on 01 June 2015

Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses

artículo científico publicado en 2019

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials

artículo científico publicado en 2008

Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review

artículo científico publicado en 2010

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

scientific article published on 13 June 2019

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

artículo científico publicado en 2017

Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease

scientific article published on 30 April 2020

Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials

Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials

artículo científico publicado en 2015

Efficacy, safety and immunogenicity of biosimilars in inflammatory bowel diseases: A systematic review

artículo científico publicado en 2016

Emerging therapies for the treatment of ulcerative colitis

artículo científico publicado en 2020

Emerging treatment options for extraintestinal manifestations in IBD

artículo científico publicado en 2020

Endoscopic balloon dilation of colorectal strictures complicating Crohn's disease: a multicenter study

artículo científico publicado en 2020

Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED).

artículo científico publicado en 2013

Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses

Environmental exposures and the risk of inflammatory bowel disease: a case-control study from Saudi Arabia

artículo científico publicado en 2020

Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study

artículo científico publicado en 2020

Epidemiology and natural history of hepatitis C

artículo científico publicado en 2005

Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD).

artículo científico

Erratum: Corrigendum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

scholarly article published in Nature Genetics

Evolution of infliximab biosimilar in inflammatory bowel disease: from intravenous to subcutaneous CT-P13

artículo científico publicado en 2020

Evolving definitions of remission in Crohn's disease

artículo científico publicado en 2013

Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective

scientific article published on 01 February 2020

Evolving strategies and goals of treatment in ulcerative colitis

artículo científico publicado en 2018

Evolving therapeutic goals in Crohn's disease management

scientific article published on 04 November 2019

Evolving treatment algorithms in Crohn's Disease

artículo científico publicado en 2016

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease

artículo científico

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

artículo científico publicado en 2015

Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice

artículo científico publicado en 2017

Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based Study

artículo científico publicado en 2017

Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

artículo científico publicado en 2013

Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review

scientific article published on 14 September 2019

Fecal calprotectin for the diagnosis of bowel inflammation in patients with rheumatological diseases: a systematic review

artículo científico publicado en 2019

Filgotinib in Crohn’s Disease: JAK Is Back

artículo científico publicado en 2017

First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

artículo científico

Flare-IBD: development and validation of a questionnaire based on patients' messages on an internet forum for early detection of flare in inflammatory bowel disease: study protocol

artículo científico publicado en 2020

Folate metabolism and colorectal carcinogenesis

artículo científico publicado en 2004

French national consensus clinical guidelines for the management of Crohn's disease

artículo científico publicado en 2016

French national consensus clinical guidelines for the management of ulcerative colitis

artículo científico publicado en 2016

Gastric intrinsic factor deficiency with combined GIF heterozygous mutations and FUT2 secretor variant.

artículo científico publicado en 2013

Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn disease

scientific article published on July 2011

Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice

artículo científico publicado en 2017

Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease

artículo científico publicado en 2009

Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer

artículo científico publicado en 2020

Gossypiboma successfully removed by upper-GI endoscopy

artículo científico publicado en 2007

Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review

artículo científico publicado en 2015

Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences

artículo científico publicado en 2019

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

artículo científico publicado en 2011

Haematopoietic stem cell autotransplantation for refractory Crohn's disease: ready for prime time?

scientific article published on 14 October 2011

Head-to-head Comparative Studies: Challenges and Opportunities?

artículo científico publicado en 2017

Head-to-head trials in inflammatory bowel disease: past, present and future

artículo científico publicado en 2020

Helicobacter pylori serologic status has no influence on the association between fucosyltransferase 2 polymorphism (FUT2 461 G->A) and vitamin B-12 in Europe and West Africa

artículo científico publicado en 2012

Hepatitis A acquired from an asymptomatic adopted child

artículo científico publicado en 2006

Hepatotoxicity associated with herbal remedies: clinical, biological, histological data and the mechanisms involved in some typical examples

artículo científico publicado en 2004

Herpes simplex virus colitis complicating the course of a patient with Crohn's disease and cirrhosis: an underestimated association?

artículo científico publicado en 2010

Herpes zoster and vaccination strategies in inflammatory bowel diseases: a practical guide

artículo científico publicado en 2020

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review for Development of a Core Outcome Set.

artículo científico publicado en 2018

High risk of anal and rectal cancer in patients with anal and/or perianal Crohn's disease

artículo científico publicado en 2017

Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy

scientific article published on 10 September 2020

Histologic features predicting postoperative Crohn's disease recurrence

artículo científico publicado en 2015

Histologic remission: the ultimate therapeutic goal in ulcerative colitis?

artículo científico

Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure

scientific article published on 01 February 2020

Histological healing: should it be considered as a new outcome for ulcerative colitis?

scientific article published on 10 January 2020

How NOD2 mutations predispose to Crohn's disease?

artículo científico publicado en 2007

Hypertrigyceridemia during infliximab therapy

artículo científico publicado en 2013

IBD immunopathogenesis: A comprehensive review of inflammatory molecules

artículo científico publicado en 2017

IBD in 2013: enriching the therapeutic armamentarium for IBD.

artículo científico publicado en 2013

IBD serological panels: facts and perspectives

artículo científico publicado en 2007

IBD: To switch or not to switch: that is the biosimilar question

artículo científico publicado en 2017

IL-17 inhibitors and inflammatory bowel diseases: a post-marketing study in Vigibase®

artículo científico publicado en 2021

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

artículo científico

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease

article

Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures

artículo científico publicado en 2011

IgE antibodies and skin tests in immediate hypersensitivity reactions to infliximab in inflammatory bowel disease: impact on infliximab retreatment

artículo científico publicado en 2015

Ileal ulcers not responding to infliximab therapy: think about intestinal ganglioneuromatosis

artículo científico publicado en 2014

Immunomodulators for the treatment of Crohn's disease in adults: optimal use and prospects for future drug treatments

artículo científico publicado en 2016

Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn′s Disease: A French Population-Based Study

article

Impact of HIV infection on the course of inflammatory bowel disease and drug safety profile: a multicenter GETAID study

scientific article published on 24 December 2020

Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study

artículo científico publicado en 2016

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

artículo científico publicado en 2020

Impact of age at diagnosis on natural history of patients with elderly-onset ulcerative colitis: A French population-based study

artículo científico publicado en 2018

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

artículo científico publicado en 2011

Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases

artículo científico publicado en 2015

Impact of inflammatory bowel diseases on working life: A French nationwide survey

artículo científico publicado en 2019

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience

artículo científico publicado en 2013

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort

artículo científico publicado en 2017

Implementation of the French national consensus for the management of ulcerative colitis into clinical practice

artículo científico publicado en 2016

Implementing changes in clinical practice to improve the management of Crohn's disease

artículo científico publicado en 2012

Implementing the Concept of Continuous Clinical Response Into Clinical Practice for Ulcerative Colitis

artículo científico publicado en 2016

Improving quality of care in inflammatory bowel disease: what changes can be made today?

artículo científico publicado en 2014

Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts

scientific article published on 30 April 2020

Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics

artículo científico publicado en 2011

Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

artículo científico publicado en 2011

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, or Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.

artículo científico publicado en 2018

Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease

artículo científico publicado en 2017

Infection risk with biologic therapy in patients with inflammatory bowel disease

artículo científico publicado en 2017

Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn's and Colitis Organization (ECCO)

artículo científico publicado en 2020

Inflammatory bowel disease: estimates from the global burden of disease 2017 study

scientific article published on 29 October 2019

Inflammatory bowel diseases and COVID-19: the invisible enemy

scientific article published on 16 April 2020

Infliximab 10 mg/kg every 3 weeks for Crohn's disease

scientific article published on 01 November 2010

Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease

scientific article published on 28 April 2020

Infliximab and azathioprine for Crohn's disease: a super-sonic combination?

artículo científico publicado en 2010

Infliximab biosimilar CT-P13 for inflammatory bowel disease

artículo científico publicado en 2018

Infliximab for refractory ulcerative proctitis

scientific article published on 08 March 2010

Infliximab for severe peripheral ulcerative keratopathy revealing Crohn's disease

artículo científico publicado en 2011

Insight into the role of TSLP in inflammatory bowel diseases

artículo científico publicado en 2016

Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease

artículo científico publicado en 2009

Integrating Patient-Reported Outcomes Into Treat-to-Target Monitoring Algorithms

artículo científico publicado en 2018

Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?

scientific article published on 01 January 2019

Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases

artículo científico publicado en 2016

Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review

artículo científico publicado en 2015

Intestinal permeability and cirrhosis

artículo científico publicado en 2006

Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2016

Introduction to the Special Issue: The Present and Future of IBD Care

artículo científico publicado en 2020

Iron deficiency anaemia

artículo científico

Is Diffusion-weighted Magnetic Resonance Imaging for Assessing Crohn's Disease Ready for Prime Time? Experience with the Nancy Score

artículo científico publicado en 2015

Is Mesalamine Effective for the Induction of Remission in Crohn's Disease?

artículo científico publicado en 2017

Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?

artículo científico publicado en 2018

Is the dose of thioguanine the key to better safety profile?

scientific article published on 14 December 2010

Is ulcerative colitis proctitis associated with an increased risk of colorectal cancer?

artículo científico publicado en 2009

It is time to revise the STRIDE guidelines determining therapeutic goals for treat-to-target in inflammatory bowel disease

artículo científico publicado en 2017

JAK inhibition in inflammatory bowel disease

artículo científico publicado en 2017

JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis

artículo científico publicado en 2020

JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?

scientific article published on 21 June 2019

Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment

artículo científico publicado en 2013

Keeping the (S)toolbox Alive Outside of the Body for Drugs Discovery

artículo científico publicado en 2017

Keratoconus in Inflammatory Bowel Disease Patients: A Cross-sectional Study

artículo científico publicado en 2015

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis

artículo científico publicado en 2020

Knowledge of 5-aminosalicylic acid nephrotoxicity and adherence to kidney function monitoring of patients with inflammatory bowel disease

scientific article published on 30 November 2020

Letter: addition of methotrexate neither restores clinical response nor improves the pharmacokinetic profile of vedolizumab-treated patients

artículo científico publicado en 2017

Letter: fatigue, a growing concern in inflammatory bowel diseases ⬇️

artículo científico publicado el 1 de agosto de 2013

Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease

artículo científico publicado en 2015

Letter: mucosal healing in ulcerative colitis – higher relevance than in Crohn's disease? Authors' reply ⬇️

artículo científico publicado el 1 de julio de 2013

Leukoapheresis in Crohn's disease: the final curtain? ⬇️

artículo científico publicado el 14 de agosto de 2012

Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX

artículo científico publicado en 2020

Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab

artículo científico publicado en 2016

Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts

artículo científico publicado en 2010

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

artículo científico publicado en 2018

Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: a population-based study

artículo científico publicado en 2013

Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study

scientific article published on 19 September 2020

Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab

artículo científico publicado en 2013

Long-term safety of approved biologics for ulcerative colitis

scientific article published on 22 May 2020

Looking for innovative digital solutions to optimize patient recruitment in IBD trials

artículo científico publicado en 2020

Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis

artículo científico publicado en 2018

Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review

artículo científico publicado en 2011

Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases

artículo científico publicado en 2020

Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11

artículo científico publicado en 2019

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice

artículo científico publicado en 2017

MRI scoring indices for evaluation of disease activity and severity in Crohn’s disease

artículo científico publicado en 2015

Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation

artículo científico publicado en 2015

Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study

scientific article published on 13 January 2020

Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2016

Management of inflammatory bowel disease in France: a nationwide survey among private gastroenterologists

artículo científico publicado en 2014

Management of patients with inflammatory bowel disease and spondyloarthritis

artículo científico publicado en 2017

Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a

artículo científico publicado en 2020

Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases

artículo científico publicado en 2016

Medico-surgical Management: A Solid Therapeutic Pillar for Improved Patients' Outcomes in Inflammatory Bowel Diseases

artículo científico publicado en 2019

Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease

artículo científico publicado en 2011

Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

artículo científico publicado en 2006

Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations

scientific article published on 01 November 2018

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

scientific journal article

Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases ⬇️

artículo científico publicado el 3 de octubre de 2011

Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease

scientific article published on 25 September 2018

Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China

artículo científico publicado en 2008

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

artículo científico publicado en 2015

Methotrexate for psoriasiform lesions associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease ⬇️

artículo científico publicado el 2 de abril de 2012

Methyl deficient diet aggravates experimental colitis in rats

artículo científico publicado en 2011

Methyl donor deficiency affects small-intestinal differentiation and barrier function in rats

artículo científico publicado en 2012

Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hypomethylation and decreased ER-α, ERR-α, and HNF-4α in the rat liver

artículo científico publicado en 2012

Methyl-deficient diet promotes colitis and SIRT1-mediated endoplasmic reticulum stress

artículo científico publicado en 2015

Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa

artículo científico publicado en 2008

Microbiota in digestive cancers: our new partner?

artículo científico publicado en 2017

Microscopic features for initial diagnosis and disease activity evaluation in inflammatory bowel disease

artículo científico publicado en 2013

Microscopic features of colorectal neoplasia in inflammatory bowel diseases

artículo científico publicado en 2014

Milan Ultrasound Criteria are accurate in assessing disease activity in ulcerative colitis: External validation

artículo científico publicado en 2020

Mo1823 Highlighting of Epidemic Areas of Crohn's Disease in a Population-Based Registry Over 22 Years: Genetic or Environmental Cause?

Modern use of 5-aminosalicylic acid compounds for ulcerative colitis

scientific article published on 18 September 2019

Modulation of sphingosine-1-phosphate in inflammatory bowel disease

artículo científico publicado en 2017

Modulation of sphingosine-1-phosphate in ulcerative colitis

artículo científico publicado en 2020

Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study

scientific article published on 16 December 2019

Monitoring of inflammatory bowel disease in 2019: A French consensus for clinical practice

artículo científico publicado en 2020

Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study

artículo científico publicado en 2013

Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation study

artículo científico publicado en 2020

Moving towards disease modification in inflammatory bowel disease therapy

artículo científico

Mucosal healing with anti-TNF antibodies

artículo científico

Mucosal healing—EXTENDing our knowledge in Crohn's disease ⬇️

artículo científico publicado el 24 de abril de 2012

Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group

scientific article published on 04 December 2019

NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease

artículo científico publicado en 2007

NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation

Natalizumab: a promising treatment for Crohn's disease

artículo científico publicado en 2006

Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

artículo científico publicado en 2017

Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study

artículo científico publicado en 2016

Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study

artículo científico publicado en 2013

Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice

artículo científico publicado en 2012

New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases

scientific article published on 11 December 2020

New drugs in the pipeline for the treatment of inflammatory bowel diseases: what is coming?

artículo científico publicado en 2020

New mechanisms and targets for IBD Therapy: translational gastroenterology comes of age.

artículo científico publicado en 2013

New therapeutic goals in inflammatory bowel diseases

artículo científico publicado en 2014

Next generation of small molecules in inflammatory bowel disease

artículo científico publicado en 2016

Nocebo effect and biosimilars in inflammatory bowel diseases: what's new and what's next?

artículo científico publicado en 2020

Nonfistulizing perianal Crohn's disease: clinical features, epidemiology, and treatment

scientific article published on August 2010

Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease

artículo científico publicado en 2019

Novel therapeutic targets for inflammatory bowel disease

artículo científico

Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease

artículo científico publicado en 2012

Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials ⬇️

artículo científico publicado el 7 de mayo de 2013

Optimizing conventional medical therapies in inflammatory bowel disease in 2014.

artículo científico

Optimizing thiopurine therapy in inflammatory bowel disease

artículo científico publicado en 2010

Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

artículo científico publicado en 2019

Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic

scientific article published on 19 May 2020

PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue

artículo científico publicado en 2017

PF-00547659 for the treatment of Crohn's disease and ulcerative colitis

artículo científico publicado en 2018

PK, PD and interactions: the new scenario with JAK inhibitors and S1P Receptor Modulators, two classes of small molecule drugs, in IBD

artículo científico publicado en 2020

Paradoxical gastrointestinal effects of interleukin-17 blockers

artículo científico publicado en 2020

Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations

artículo científico publicado en 2016

Patient's profiling for therapeutic management of inflammatory bowel disease: a tailored approach

scientific article published on 19 May 2020

Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients

artículo científico publicado en 2016

Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease

artículo científico publicado en 2014

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

scientific article published on 31 October 2020

Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease

artículo científico publicado en 2016

Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group

artículo científico publicado en 2020

Perianal Crohn's disease findings other than fistulas in a population-based cohort

artículo científico publicado en 2011

Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon

artículo científico publicado en 2010

Personalised medicine in inflammatory bowel diseases: a patient survey

scientific article published on 20 January 2019

Pharmacokinetics of Infliximab and Reduction of Treatment for Inflammatory Bowel Diseases.

artículo científico

Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis.

artículo científico publicado en 2014

Pharmacological Prevention of Postoperative Recurrence in Crohn's Disease

artículo científico publicado en 2020

Phase 1, 2 and 3 trials in inflammatory bowel diseases: a practical guide for the non-specialist

artículo científico publicado en 2020

Photodynamic therapy as a new treatment modality for inflammatory and infectious conditions

artículo científico

Photodynamic therapy relieves colitis and prevents colitis-associated carcinogenesis in mice

artículo científico publicado en 2015

Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

artículo científico publicado en 2018

Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease

artículo científico publicado en 2012

Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study

artículo científico publicado en 2018

Point-of-care ultrasound in Inflammatory Bowel Disease

scientific article published on 17 July 2020

Positioning Therapies in Ulcerative Colitis

scientific article published on 23 January 2020

Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis

artículo científico publicado en 2018

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice

artículo científico publicado en 2017

Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block

scientific article published on 13 February 2020

Post-operative complications in elderly onset inflammatory bowel disease: a population-based study

artículo científico publicado en 2018

Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study

artículo científico publicado en 2015

Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball?

artículo científico publicado en 2015

Predictors for short bowel syndrome in Crohn's disease

scientific article published on 14 September 2020

Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy

artículo científico publicado en 2010

Preoperative magnetic resonance enterography in predicting findings and optimizing surgical approach in Crohn's disease

artículo científico publicado en 2013

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis

artículo científico publicado en 2013

Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome.

artículo científico publicado en 2016

Prevalence of cytomegalovirus infection in steroid-refractory Crohn's disease

artículo científico publicado en 2012

Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis

scientific article published on 22 November 2019

Prevalence of esophageal squamous papilloma (ESP) and associated cancer in northeastern France

artículo científico publicado en 2015

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France

artículo científico publicado en 2010

Preventing Collateral Damage in Crohn's Disease: The Lémann Index

artículo científico publicado en 2016

Preventing disability in inflammatory bowel disease

artículo científico publicado en 2017

Preventing postoperative recurrence in Crohn's disease: what does the future hold?

artículo científico publicado en 2013

Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.

artículo científico publicado en 2014

Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence

artículo científico publicado en 2016

Primetime for e-health in IBD?

scientific article published on 25 January 2017

Probe-based confocal laser endomicroscopy for in vivo assessment of histological healing in ulcerative colitis: development and validation of the ENHANCE index

artículo científico publicado en 2020

Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease

artículo científico publicado en 2017

Protecting patients with IBD during the COVID-19 pandemic

artículo científico publicado en 2020

Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease

scientific article published on 01 October 2020

Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients

artículo científico publicado en 2019

Psychological Functioning of Patients With Inflammatory Bowel Disease

scientific article published on 01 August 2019

Publisher Correction: Crohn's disease

artículo científico publicado en 2020

Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach

scientific article published on 03 July 2018

Reactivation of viral hepatitis in immunosuppressed patients: an ounce of prevention is worth a pound of cure

scientific article published on 18 November 2010

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

scientific article published on 13 November 2019

Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases

artículo científico publicado en 2011

Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis

artículo científico publicado en 2020

Reply to: Dr Macaluso's Letter

artículo científico publicado en 2016

Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists

artículo científico publicado en 2010

Response

scientific article published on 19 June 2020

Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial

scientific article published on 03 August 2018

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease

artículo científico

Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseases

artículo científico publicado en 2013

Review article: faecal calprotectin and histologic remission in ulcerative colitis

artículo científico publicado en 2020

Review article: remission rates achievable by current therapies for inflammatory bowel disease ⬇️

artículo científico publicado el 15 de febrero de 2011

Review article: the natural history of postoperative Crohn's disease recurrence ⬇️

artículo científico publicado el 7 de febrero de 2012

Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and future ⬇️

artículo científico publicado el 13 de marzo de 2013

Review article: treating-to-target for inflammatory bowel disease-associated anaemia

artículo científico publicado en 2018

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy

artículo científico publicado en 2016

Risk of Late Post-Operative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers

artículo científico publicado en 2020

Risk of Melanoma in Patients Who Receive Thiopurines for Inflammatory Bowel Disease Is Not Increased

Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies

artículo científico

Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis

artículo científico publicado en 2014

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

artículo científico publicado en 2020

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

artículo científico publicado en 2020

Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis

scientific article published on 09 January 2020

Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses

artículo científico publicado en 2018

Self-insertion of a nasogastric tube for home enteral nutrition: a pilot study

artículo científico publicado en 2013

Self-medication with steroids in inflammatory bowel disease

artículo científico publicado en 2015

Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience

artículo científico publicado en 2020

Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy

artículo científico publicado en 2010

Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men.

artículo científico publicado en 2018

Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?

artículo científico publicado en 2018

Statins and inflammatory bowel disease: Where do we stand?

artículo científico publicado en 2020

Step-up and top-down approaches to the treatment of Crohn's disease: early may already be too late

scientific article published on 04 September 2008

Stopping infliximab in Crohn’s disease: still an ongoing STORI

artículo científico publicado en 2012

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

artículo científico publicado en 2015

Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn's disease

artículo científico publicado en 2013

Surgery for Crohn's disease during pregnancy: A nationwide survey

scientific article published on 23 April 2020

Surgery for adult Crohn's disease: what is the actual risk?

artículo científico publicado en 2011

Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004)

artículo científico publicado en 2012

Surgical rates in the era of biological therapy: up, down or unchanged?

artículo científico publicado en 2017

Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease

artículo científico publicado en 2016

Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index.

artículo científico publicado en 2017

Systematic review on IBD patients with COVID-19: it is time to take stock

artículo científico publicado en 2020

Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease

artículo científico publicado en 2020

Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease

artículo científico publicado en 2018

Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis

artículo científico publicado en 2017

Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

artículo científico publicado en 2014

Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease

scientific article published on 31 July 2018

TNF inhibitors and risk of malignancy in patients with inflammatory bowel diseases: a systematic review

scientific article published on 11 September 2020

TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice

artículo científico publicado en 2017

Targeting SMAD7 in Crohn’s Disease by Mongersen: Therapeutic Revolution Under Way?

artículo científico publicado en 2015

Targeting the gut layers in Crohn's disease: mucosal or transmural healing?

artículo científico publicado en 2020

Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!

artículo científico publicado en 2018

The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Update: Emerging Trends in Clinical Practice

artículo científico publicado en 2016

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 01 February 2020

The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials

artículo científico publicado en 2016

The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease

artículo científico publicado en 2020

The POCER Trial: Bet on Active Care

artículo científico publicado en 2015

The association of autoimmune diseases with pediatric ulcerative colitis does not influence its disease course

artículo científico publicado en 2015

The day after COVID-19 in IBD: how to go back to 'normal'

artículo científico publicado en 2020

The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis

artículo científico publicado en 2020

The effect of immune therapy on surgical site infection following Crohn's Disease resection ⬇️

artículo científico publicado el 3 de mayo de 2013

The extra burden of infliximab infusions in inflammatory bowel disease

artículo científico publicado en 2013

The management of emergency hospital visits for inflammatory bowel diseases: A French national expert consensus report

scientific article published on 14 November 2019

The natural history of Crohn's disease in children: a review of population-based studies

artículo científico publicado en 2016

The natural history of adult Crohn's disease in population-based cohorts

artículo científico publicado en 2009

The nocebo effect: a clinical challenge in the era of biosimilars

artículo científico publicado en 2018

Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study

artículo científico publicado en 2013

Thiopurine Metabolism in the Era of Combotherapy

artículo científico publicado en 2016

Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients?

artículo científico publicado en 2014

Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases

artículo científico publicado en 2020

Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis

artículo científico publicado en 2014

Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives

artículo científico publicado en 2017

Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis

scientific article published on 13 July 2020

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

artículo científico publicado en 2019

Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies

artículo científico publicado en 2013

Thrombosis in IBD in the era of JAK inhibition

artículo científico publicado en 2020

Time to include patients with ulcerative proctitis in clinical trials

scientific article published on 01 December 2019

Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"?

scientific article published on 01 November 2019

Tofacitinib Is the Right OCTAVE for Ulcerative Colitis

artículo científico publicado en 2017

Tofacitinib for Acute Severe Colitis: When the going Gets Tough, the Tough Get Going

artículo científico publicado en 2020

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience.

artículo científico publicado en 2019

Tofacitinib: Janus Bifrons in Ulcerative Colitis Treatment ⬇️

artículo científico publicado el 23 de marzo de 2013

Tolerability of one hour 10 mg/kg infliximab infusions in patients with inflammatory bowel disease

artículo científico publicado en 2012

Tolerability of one hour 10mg/kg infliximab infusions in inflammatory bowel diseases: a prospective multicenter cohort study

scientific article published on 30 August 2013

Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review

scientific article published on 17 July 2020

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

artículo científico publicado en 2014

Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties

scientific article published on 27 January 2020

Treat to target or "treat to clear" in inflammatory bowel diseases: one step further?

artículo científico publicado en 2020

Treat to target: The role of histologic healing in inflammatory bowel diseases: A systematic review and meta-analysis

scientific article published on 30 September 2020

Treat to target: a proposed new paradigm for the management of Crohn's disease

artículo científico

Treatment Algorithms for Crohn's Disease

scientific article published on 13 March 2020

Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience

artículo científico publicado en 2017

Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience

scientific article published on 01 April 2019

Treatment algorithms in Crohn's - up, down or something else?

artículo científico publicado en 2014

Treatment of extraintestinal manifestations in inflammatory bowel disease

artículo científico

Treatment of fibrostenotic and fistulizing Crohn's disease

artículo científico publicado en 2012

Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study

artículo científico publicado en 2016

Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks

artículo científico publicado en 2020

Two cases of successful ustekinumab treatment for non-infectious uveitis associated with Crohn's disease

artículo científico publicado en 2019

Ulcerative Colitis and Crohn's Disease Have the Same Burden and Goals for Treatment

artículo científico publicado en 2019

Ulcerative colitis

artículo científico publicado en 2016

Ulcerative colitis

scientific article published on 10 September 2020

Ulcerative colitis as a progressive disease: the forgotten evidence

artículo científico

Ulcerative colitis as a sole mucosal disease: another misunderstanding?

scientific article published on 11 July 2011

Ulcerative colitis: Natural history--an optimistic message from Norway

artículo científico publicado en 2009

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

scientific article published on 06 February 2019

Update on Crohn's disease and ulcerative colitis

artículo científico publicado en 2011

Urinary tract infections in hospitalized inflammatory bowel disease patients: a 10-year experience

artículo científico publicado en 2011

Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases

artículo científico publicado en 2019

Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts

artículo científico publicado en 2011

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2019

Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID

scientific article published on 19 August 2020

Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review

scientific article published on 24 December 2020

VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease

artículo científico publicado en 2014

Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies

artículo científico

Vaccination for influenza and pneumococcus in patients with gastrointestinal cancer or inflammatory bowel disease: A prospective cohort study of methods for improving coverage

scientific article published on 28 November 2018

Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis

artículo científico publicado en 2017

Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort

artículo científico publicado en 2015

Validation of the Red Flags Index for Early Diagnosis of Crohn's Disease: A Prospective Observational IG-IBD Study Among General Practitioners

scientific article published on 28 September 2020

Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal

artículo científico publicado en 2017

Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease

scientific article published on 20 May 2020

Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine

artículo científico publicado en 2007

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

artículo científico publicado en 2019

Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review

scientific article published on 01 December 2019

Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis

scientific article published on 01 August 2019

Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?

artículo científico publicado en 2020

Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients

scientific article published on 20 February 2020

Vedolizumab for the treatment of Crohn's disease.

artículo científico publicado en 2018

Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing

artículo científico publicado en 2019

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

artículo científico publicado en 2019

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey

scientific article published on 13 May 2020

What Is the Patient’s Perspective: How Important Are Patient-Reported Outcomes, Quality of Life and Disability? ⬇️

artículo científico publicado el 30 de septiembre de 2010

What Proportion of Patients With Inflammatory Bowel Disease Want to Stop Infliximab Therapy?

artículo científico publicado en 2016

Which MRI Score and Technique Should Be Used for Assessing Crohn's Disease Activity?

artículo científico publicado en 2020

Why should we define and target early Crohn's disease? ⬇️

artículo científico publicado el 1 de mayo de 2011

Will COVID-19 infection be less severe in ulcerative colitis than in Crohn's patients due to a lower rate of smokers?

scientific article published on 18 April 2020

Zinc-Alpha-2-Glycoprotein in Inflammatory Bowel Disease

artículo científico publicado en 2018

[Circumstances of the diagnosis and clinical course of inflammatory bowel disease]

artículo científico publicado en 2005

[Disability in inflammatory bowel disease: an underestimated problem]

artículo científico publicado en 2014

[Epigenetic changes and liver carcinogenesis]

artículo científico publicado en 2006

[Mediastinal lymph node and vertebral metastases 3 years after liver transplantation for cholangiocarcinoma: 2 unusual localizations]

scientific article published on 01 April 2005

[Pancreatic pseudocysts of the right hepatic lobe during acute biliary pancreatitis]

artículo científico publicado en 2005

[Probable hepatoxicity from epigallocatecol gallate used for phytotherapy]

scientific article published on 01 April 2004

[Thiopurines in inflammatory bowel disease: what's new ?]

scientific article published on 01 October 2019

mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease

artículo científico publicado en 2019

Lista de obras de Laurent Peyrin-Biroulet

"Comment on a retraction": author response.

25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management

5-Aminosalicylates and renal function monitoring in inflammatory bowel disease: a nationwide survey

5-Aminosalicylic acid and chemoprevention: does it work?

A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool

A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials

A Systematic Review for the Development of a Core Outcome Set for Ulcerative Colitis Clinical Trials

A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review ⬇️

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

A practical guide for faecal calprotectin measurement: myths and realities

A practical guide to assess the Nancy histological index for UC.

A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease

A snapshot of the ongoing clinical research on COVID-19

Accuracy of Diffusion-weighted Magnetic Resonance Colonography in Assessing Mucosal Healing and the Treatment Response in Patients with Ulcerative Colitis

Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study.

Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer

Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.

Acute hepatic cytolysis following H1N1 vaccination in a patient with Crohn's disease on infliximab

Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study

Adalimumab in ulcerative colitis: hypes and hopes

Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study

Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Addressing current treatment challenges in Crohn's disease in real life: a physician's survey

Adherence to adalimumab therapy in Crohn's disease: a French multicenter experience.

Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review

Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting

Advances in the treatment of ulcerative colitis

An Anti-Migration Self-Expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From the Getaid and the Sfed

An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials

Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience

Anti-TNF Therapy in Inflammatory Bowel Diseases

Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach

Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?

Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?

Anti-tumor necrosis factor-α monotherapy versus combination therapy with an immunomodulator in IBD.

Antimycobacterial therapy in Crohn's disease: game over?

Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?

Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases

Are we improving disease outcomes in IBD? A view from the epidemiology side

Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials

Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis

Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.

Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn's disease

Author Correction: Crohn's disease

Author Correction: Crohn's disease

Author Correction: Head-to-head trials in inflammatory bowel disease: past, present and future

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.

Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study

Azathioprine in Early Crohn’s Disease: Time to Revisit Patient Selection and End Points for Clinical Trials and/or Azathioprine Efficacy?

Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response

Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic

Beclomethasone dipropionate: a second chance for topical steroids as maintenance therapy in ileal Crohn's disease

Beliefs and behaviour about smoking among inflammatory bowel disease patients

Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?

Big data in IBD: a look into the future

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.

Biologic agents for IBD: practical insights

Biologic therapies in ulcerative colitis: primi inter pares?

Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis

Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13.

Biosimilar switching in inflammatory bowel disease: from evidence to clinical practice

Biosimilars for the management of inflammatory bowel diseases: economic considerations

Biosimilars in IBD: from theory to practice

Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

Biosimilars of adalimumab: the upcoming challenge in IBD

Bowel Damage Assessment in Crohn’s Disease by Magnetic Resonance Imaging ⬇️

Bowel Damage as Assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn’s Disease

Bowel Damage at Diagnosis Using the Lémann Index Score in Saudi Arabian Patients With Crohn's Disease

Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile